NASOTRUSS Trademark

Trademark Overview


On Wednesday, December 13, 2023, a trademark application was filed for NASOTRUSS with the United States Patent and Trademark Office. The USPTO has given the NASOTRUSS trademark a serial number of 98312109. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, October 31, 2024. This trademark is owned by Septum Solutions, L.L.C.. The NASOTRUSS trademark is filed in the Medical Instrument Products category with the following description:

Implantable scaffolds comprising artificial materials for maintaining tissue contour; Implants comprising natural, non-living materials; Implants consisting of artificial materials; Medical instruments for use in rhinoplastic surgery recovery; Splints for nasal cavity; Splints for rhinoplastic surgery; Splints, surgical; Stent delivery systems; Stents; Supporters for medical purposes; Surgical instruments for use in rhinoplastic surgery; Surgical instruments, namely, degradable nasal splints; Surgical and medical apparatus and instruments for use in rhinoplastic surgery; Medical stents; Medical devices and apparatus, namely, surgical implants comprised primarily of artificial material and also incorporating processed animal tissue for use in plastic reconstructive surgery, and repair, reinforcement or buttressing of soft tissue, and parts and fittings therefor; Surgical implants comprised of artificial materials; Surgical implants comprising artificial material; Surgical implants compr...

General Information


Serial Number98312109
Word MarkNASOTRUSS
Filing DateWednesday, December 13, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, October 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesImplantable scaffolds comprising artificial materials for maintaining tissue contour; Implants comprising natural, non-living materials; Implants consisting of artificial materials; Medical instruments for use in rhinoplastic surgery recovery; Splints for nasal cavity; Splints for rhinoplastic surgery; Splints, surgical; Stent delivery systems; Stents; Supporters for medical purposes; Surgical instruments for use in rhinoplastic surgery; Surgical instruments, namely, degradable nasal splints; Surgical and medical apparatus and instruments for use in rhinoplastic surgery; Medical stents; Medical devices and apparatus, namely, surgical implants comprised primarily of artificial material and also incorporating processed animal tissue for use in plastic reconstructive surgery, and repair, reinforcement or buttressing of soft tissue, and parts and fittings therefor; Surgical implants comprised of artificial materials; Surgical implants comprising artificial material; Surgical implants comprising artificial material and associated surgical instrument sets

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, December 13, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSeptum Solutions, L.L.C.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressJacksonville, TX 75766

Trademark Events


Event DateEvent Description
Wednesday, December 13, 2023NEW APPLICATION ENTERED
Sunday, March 17, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 12, 2024ASSIGNED TO EXAMINER
Friday, July 26, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 28, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 28, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 28, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 26, 2024NON-FINAL ACTION E-MAILED
Friday, July 26, 2024NON-FINAL ACTION WRITTEN